Joan S. Brugge, Ph.D. | Catalio Capital Management

Joan S. Brugge, Ph.D.

Venture Partner

Director of the Ludwig Cancer Center & Professor of Cell Biology, Harvard Medical School

Cancer Biology, Breast Cancer, Epithelial Tumors

‍

EDUCATION

BA - Northwestern University

PhD - Baylor College of Medicine

Postdoctoral Fellow - University of Colorado Medical Center

‍

AWARDS AND ACCOLADES

National Academy of Sciences, 2001

American Academy of Arts & Sciences, 2000

Memorial Sloan Kettering Medal for Outstanding Contributions to Biomedical Research, 2016

American Cancer Society Medal of Honor Recipient, 2019

American Society of Clinical Oncology Award

The Hope Funds for Cancer Research Award of Excellence, 2016

Brinker Award for Scientific Distinction, 2014

American Association of Science

‍

COMPANIES AND BOARDS

Co-Founder: ARIAD Pharmaceuticals, Inc. (acquired by Takeda)

Board of Directors: ARIAD Pharmaceuticals, Inc. (acquired by Takeda)

Scientific Advisory Board: Agios Pharmaceuticals (NASDAQ: AGIO), Effector Therapeutics, Frontier Medicines, Breast Cancer Research Foundation, Allen Institute of Cell Sciences

MEMBER OF Investment Committee

Associated Portfolio Companies

No items found.

Joan S. Brugge

Professor at Harvard Medical School

Joan S. Brugge

Professor at Harvard Medical School

Boston, Massachusetts

Overview

Work Experience

Harvard Medical School

Professor

1997 - Current

Relevant Websites